celastrol has been researched along with ly-2157299 in 1 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (ly-2157299) | Trials (ly-2157299) | Recent Studies (post-2010) (ly-2157299) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 126 | 21 | 124 |
| Protein | Taxonomy | celastrol (IC50) | ly-2157299 (IC50) |
|---|---|---|---|
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 0.044 | |
| Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | 0.2716 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.442 | |
| Activin receptor type-1B | Homo sapiens (human) | 0.199 | |
| TGF-beta receptor type-1 | Homo sapiens (human) | 0.0973 | |
| TGF-beta receptor type-2 | Homo sapiens (human) | 1.3 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.405 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.4736 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Liang, G; Sun, F; Sun, X; Zeng, L; Zhao, P; Zhu, S | 1 |
1 other study(ies) available for celastrol and ly-2157299
| Article | Year |
|---|---|
Brain-targeting biomimetic nanoparticles for codelivery of celastrol and LY2157299 for reversing glioma immunosuppression.
Topics: Albumins; Animals; Biomimetics; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Glioma; Immunosuppression Therapy; Mice; Nanoparticles; Pentacyclic Triterpenes; Pyrazoles; Quinolines; Transforming Growth Factor beta1 | 2022 |